Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Cello's Talking Taboos

19 Sep 2012 07:01

RNS Number : 5783M
Cello Group plc
19 September 2012
 



For Immediate Release

19 September 2012

 

Cello Group plc

("Cello", or "the Group")

 

 

Launch of Cello's Talking Taboos Results & Recommendations

 

Cello Group plc (AIM: CLL), the health focused insight and strategic marketing Group, is launching the results of its social responsibility programme 'Talking Taboos'.

 

Talking Taboos is a campaigning brand that aims to tackle health and social issues using Cello's experience and resources in the healthcare space. It will focus on areas where embarrassment, fear or ignorance prevents sufferers from seeking help.

 

On October 23 2012, Cello will reveal the results of a ground-breaking yearlong research study working in partnership with YoungMinds, the UK's leading children and young people's mental health and wellbeing charity. The research used a suite of services including advanced qualitative research, professional online community forums, social media discourse research integrated with a nationally representative quantitative sample of 2,500. It explores perceptions of young people who self-harm and whether they are receiving the help they so desperately need.

The study demonstrates Cello's expertise in the health sector and its commitment to stimulating discourse around pressing health and social issues. The Group has pooled its extensive knowledge and expertise with specific audiences, healthcare professionals, GP's, young people, teachers and parents to contribute to a 'whole community' view. In conjunction with YoungMinds, it will form the basis for a series of clear recommendations on how to relieve the suffering and distress experienced by those affected. Cello's communications team, led by Leith Group's Stripe Communications, will manage the media launch, targeting mainstream and health professional press as well as relevant online and social media channels. It will provide context for the growing national debate around self-harm and offer guidance and recommendations on how to better support those affected. The programme is being led by Vincent Nolan, Managing Partner of Cello Group and Founder of 2CV.

Mark Scott, Cello Group CEO, said:

 

"Talking Taboos is a great opportunity for us to show our ability to contribute to the wider social health debate by utilising our expertise in the Health sector and our market leading research and communications capabilities.

 

"It is also an ideal way for our companies to demonstrate their abilities and talents and work across the Group to deliver a comprehensive integrated project that will inform the way that self-harm is handled."

 

Enquiries:

 

Cello Group plc (www.cellogroup.com)

Mark Scott, Chief Executive

020 7812 8460

Vincent Nolan, Group Managing Partner

020 7655 9900

Cenkos

Bobbie Hilliam/Stephen Keys

020 7397 8900

Buchanan

Mark Edwards/Nicola Cronk/Clare Akhurst

020 7466 5000

 

 

 

Notes to Editors (www.cellogroup.com)

 

The launch event will be chaired by Claire Perry MP, at Portcullis House in the Houses of Parliament. For an invitation to the launch, or a copy of the report, contact talkingtaboos@stripecom.co.uk

About Cello

Cello is an insight and strategic marketing group.

The Group's strategy is to create value for shareholders by building an international marketing advisory business able to advise blue chip clients globally, with a primary focus on the pharmaceutical sector, along with other high margin client sectors.

Cello has annualised revenues in excess of £130m, annualised gross profit in excess of £65m and employs over 700 professional staff.

 

About YoungMinds

 

YoungMinds is the UK's leading charity committed to improving the emotional well-being and mental health of children and young people and empowering their parents and carers. Driven by their experiences we campaign, research and influence policy and practice. We also provide expert knowledge to professionals, parents and young people through our parents helpline, online resources, training and development, outreach work and publications. For further information visit www.youngminds.org.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFMGMLVRDGZZM
Date   Source Headline
2nd Oct 20198:40 amRNSDisposal
18th Sep 20197:00 amRNSInterim Results
23rd Aug 201910:40 amRNSHolding(s) in Company
16th Aug 20197:00 amRNSAcquisition of ISS
6th Aug 20193:07 pmRNSTotal Voting Rights
6th Aug 20197:00 amRNSNotification of Half Year Results
18th Jul 20197:00 amRNSPre-close Trading Update
20th Jun 20194:29 pmRNSDirector/PDMR Shareholding
10th Jun 20199:41 amRNSTotal Voting Rights
24th May 201912:45 pmRNSBlock listing Interim Review
20th May 20194:29 pmRNSIssue of Equity
15th May 20197:00 amRNSHolding(s) in Company
8th May 20191:30 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Statement
1st May 201912:15 pmRNSTotal Voting Rights
15th Apr 201911:12 amRNSAnnual Report and Notice of AGM
10th Apr 20197:00 amRNSCapital Markets Event
4th Apr 201910:00 amRNSTotal Voting Rights
27th Mar 20191:00 pmRNSHolding(s) in Company
21st Mar 20193:10 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSPreliminary Results
6th Mar 20191:51 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSNotice of Full Year Results
17th Jan 20197:00 amRNSPre-Close Trading Statement
14th Dec 20189:24 amRNSBlock Listing Update
23rd Nov 20183:45 pmRNSHolding(s) in Company
19th Nov 20182:45 pmRNSHolding(s) in Company
12th Nov 201811:30 amRNSDirectorate Change
5th Nov 20182:00 pmRNSDirectorate Change
31st Oct 20183:30 pmRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAppointment of Executive Director
25th Sep 20181:00 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirector/PDMR Shareholding
24th Sep 201811:39 amRNSTransfer of FTSE classification to Healthcare
21st Sep 201810:15 amRNSDirector/PDMR Shareholding
20th Sep 20184:00 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSDirector/PDMR Shareholding
19th Sep 20187:00 amRNSInterim Results
22nd Aug 20181:51 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSNotification of Half Year Results
16th Aug 20182:00 pmRNSTotal Voting Rights
16th Aug 20181:30 pmRNSBoard Changes
23rd Jul 20187:00 amRNSHolding(s) in Company
19th Jul 20187:00 amRNSPre-close Trading Update
17th Jul 20187:00 amRNSChange of registered office
4th Jul 20181:53 pmRNSHolding(s) in Company
27th Jun 201812:46 pmRNSHolding(s) in Company
22nd Jun 20184:47 pmRNSHolding(s) in Company
20th Jun 20182:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.